Doxycycline study was stopped early due to its high efficacy, International AIDS Conference hears.
AidsmapA US study that provided gay and bisexual men and transgender women with the antibiotic doxycycline to take after condomless sex was stopped a year early because of its high efficacy, the 24th International AIDS Conference in Montreal was told yesterday (26 July 2022).
The DoxyPEP study compared the incidence of gonorrhoea, chlamydia and syphilis in 374 people who were given doxycycline to take after sex with the incidence in 180 people who were not provided with the drug. It fond that doxycycline cut the risk of STIs by two-thirds.
Read the full story at Aidsmap.
For more coverage of AIDS 2022 from Aidsmap, click here.
Source : Aidsmap
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.